UK markets closed

Biofrontera AG (B8F.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
6.80+6.48 (+2,000.00%)
At close: 05:36PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 10.82M
Enterprise value 7.33M
Trailing P/E 125.80
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.34
Price/book (mrq)0.54
Enterprise value/revenue 0.23
Enterprise value/EBITDA -6.98

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-84.93%
S&P500 52-week change 326.36%
52-week high 324.78
52-week low 30.30
50-day moving average 36.97
200-day moving average 39.46

Share statistics

Avg vol (3-month) 3598
Avg vol (10-day) 3870
Shares outstanding 53.04M
Implied shares outstanding 663.81M
Float 810.28M
% held by insiders 167.60%
% held by institutions 10.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:21
Last split date 314 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -30.06%
Operating margin (ttm)13.43%

Management effectiveness

Return on assets (ttm)2.38%
Return on equity (ttm)-57.22%

Income statement

Revenue (ttm)28.63M
Revenue per share (ttm)0.46
Quarterly revenue growth (yoy)2.70%
Gross profit (ttm)N/A
EBITDA 1.13M
Net income avi to common (ttm)-8.61M
Diluted EPS (ttm)-0.21
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.1M
Total cash per share (mrq)0.03
Total debt (mrq)1.23M
Total debt/equity (mrq)8.85%
Current ratio (mrq)1.72
Book value per share (mrq)0.22

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A